Public-registry site landscape for NCT07720193, a Advanced Extrapulmonary Neuroendocrine Carcinoma study sponsored by Nanjing Leads Biolabs Co.,Ltd. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07720193 (registry record) |
| Sponsor | Nanjing Leads Biolabs Co.,Ltd |
| Condition(s) | Advanced Extrapulmonary Neuroendocrine Carcinoma |
| Phase | PHASE3 |
| Listed sites | 17 |
| Site countries | China |
Eichor generates a preliminary site-risk snapshot for NCT07720193 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →